Previous studies have shown an increase in the presence of IL-17+Foxp3+CD4+ T cells in patients with IBD, which suggests that these double-positive cells may have a dual proinflammatory and regulatory function [32]. This evidence concerns the gene CD4 and inflammatory bowel disease.